NASDAQ:BJDX - Nasdaq - US0956335097 - Common Stock - Currency: USD
1.67
+0.03 (+1.83%)
The current stock price of BJDX is 1.67 USD. In the past month the price decreased by -56.51%. In the past year, price decreased by -99.35%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 26.96 | 223.47B | ||
ISRG | INTUITIVE SURGICAL INC | 67.35 | 184.36B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.74 | 150.72B | ||
SYK | STRYKER CORP | 29.95 | 139.34B | ||
MDT | MEDTRONIC PLC | 15.76 | 107.94B | ||
BDX | BECTON DICKINSON AND CO | 14.74 | 58.89B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.25 | 44.70B | ||
IDXX | IDEXX LABORATORIES INC | 38.88 | 35.45B | ||
RMD | RESMED INC | 25.98 | 34.64B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.24 | 31.33B | ||
DXCM | DEXCOM INC | 43.43 | 28.10B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.84 | 23.53B |
Bluejay Diagnostics, Inc. operates as a diagnostic company. The company is headquartered in Acton, Massachusetts and currently employs 10 full-time employees. The company went IPO on 2021-11-10. Its product candidate, an IL-6 Test for sepsis triage, is designed to provide results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and better triage/treatment decisions. The Symphony platform is a combination of its intellectual property (IP) and exclusively licensed and patented IP that consists of a mobile device and single-use test cartridges. The Symphony platform and its initial biomarker test, Symphony IL-6 test, is suited to address a subset of the global in vitro diagnostics devices market, including sepsis, cardio-metabolic diseases, cancer and other diseases that require rapid tests. Symphony targets critical care markets where physicians must quickly determine patient acuity to identify optimal treatment regimens.
BLUEJAY DIAGNOSTICS INC
360 Massachusetts Avenue, Suite 203
Acton MASSACHUSETTS US
Employees: 10
Company Website: https://bluejaydx.com/
Investor Relations: https://ir.bluejaydx.com/
Phone: 19786310152
The current stock price of BJDX is 1.67 USD. The price increased by 1.83% in the last trading session.
The exchange symbol of BLUEJAY DIAGNOSTICS INC is BJDX and it is listed on the Nasdaq exchange.
BJDX stock is listed on the Nasdaq exchange.
BLUEJAY DIAGNOSTICS INC (BJDX) has a market capitalization of 2.07M USD. This makes BJDX a Nano Cap stock.
BLUEJAY DIAGNOSTICS INC (BJDX) currently has 10 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BJDX does not pay a dividend.
BLUEJAY DIAGNOSTICS INC (BJDX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-72.72).
The outstanding short interest for BLUEJAY DIAGNOSTICS INC (BJDX) is 0.49% of its float. Check the ownership tab for more information on the BJDX short interest.
ChartMill assigns a fundamental rating of 2 / 10 to BJDX. The financial health of BJDX is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months BJDX reported a non-GAAP Earnings per Share(EPS) of -72.72. The EPS increased by 3.3% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -86.62% | ||
ROE | -108.86% | ||
Debt/Equity | 0.02 |
ChartMill assigns a Buy % Consensus number of 43% to BJDX. The Buy consensus is the average rating of analysts ratings from 6 analysts.